So if everyone’s drug works (I know big IF) Some combination of PEG-Intron + Ribavirin + 950 Vs. Some combination of Pegasys + Copegyasis + 191 + R1626
Seems it would be a lot to pay and speculation would be the Roche regiment is more potent. Is SGP’s 503034 that much worse (heard they had trouble with non-responders but thought more trial design problem) then 950?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.